Business · 1 sources covering this

Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr

Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net profit of Rs 480.3 crore in the corresponding quarter last fiscal, Natco Pharma said in a regulatory filing. Consolidated revenue from operations in the first quarter was lower at Rs 735.2 crore in the first quarter as compared to Rs 1,328.9 cror…

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr
Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net profit of Rs 480.3 crore in the corresponding quarter last fiscal, Natco Pharma said in a regulatory filing. Consolidated revenue from operations in the first quarter was lower at Rs 735.2 crore in the first quarter as compared to Rs 1,328.9 cror…
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/c659a08d63de1a8f84f95196cef4ad622bb8c854"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr"></iframe>

Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr

How 1 sources are covering this